(Q38235803)
Statements
Advances and advantages of nanomedicine in the pharmacological targeting of hyaluronan-CD44 interactions and signaling in cancer (English)
Spyros S Skandalis
Chrisostomi Gialeli
Achilleas D Theocharis
scientific article published on January 2014